WGS
GeneDx Holdings Corp.
NASDAQ: WGS · HEALTHCARE · DIAGNOSTICS & RESEARCH
$34.71
+0.58% today
Updated 2026-05-06
Market cap
$1.91B
P/E ratio
—
P/S ratio
4.48x
EPS (TTM)
$-0.73
Dividend yield
—
52W range
$55 – $171
Volume
1.0M
GeneDx Holdings Corp. (WGS) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | — | $251.64M | $554.09M | $545.26M | $418.76M | $419.38M |
| Cash & equivalents | — | $108.13M | $400.57M | $137.40M | $99.68M | $85.21M |
| Current assets | $163.81M | $174.11M | $483.54M | $212.62M | $182.34M | $197.97M |
| Total liabilities | — | $247.25M | $165.99M | $291.56M | $190.74M | $174.13M |
| Current liabilities | $40.19M | $73.44M | $101.28M | $144.30M | $58.82M | $54.82M |
| Long-term debt | — | $18.97M | $11.00M | $6.25M | $52.69M | $51.91M |
| Shareholder equity | — | $4.39M | $388.10M | $253.71M | $228.02M | $245.25M |
| Retained earnings | $-88.71M | $-330.05M | $-575.44M | $-1.12B | $-1.30B | $-1.35B |
| Accounts receivable | $21.64M | $32.33M | $26.56M | $43.34M | $32.82M | $37.63M |
| Inventory | $15.98M | $24.96M | $33.46M | $13.66M | $8.78M | $10.65M |
| Goodwill | — | — | — | — | — | — |